As occurs in extrinsic inflammation, an increasingly large body of evidence indicates that PGE2 promotes tumor growth through autocrine and paracrine mechanisms by activating EP receptors present both in cancer cells and in stromal cells and by transactivating growth factor receptor tyrosine kinases (RTKs) frequently upregulated in cancer cells [15,98]. Here, NTRK1 is linked to cancer.